📰 Score Test News
Page 3 - Score Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Score Test. Real-time updates on events, politics, business and more.
April 2, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]
April 2, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]
March 29, 2024
Values First Advisors Inc. increased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 21.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,973 shares of the medical research company’s stock after purchasing an additional 2,329 shares during the […]
March 9, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report)’s stock price rose 7.3% during mid-day trading on Thursday . The stock traded as high as $60.52 and last traded at $60.35. Approximately 1,181,042 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 1,954,303 shares. The stock had previously closed […]
February 29, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CEO Kevin T. Conroy sold 6,263 shares of the company’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $56.89, for a total transaction of $356,302.07. Following the completion of the sale, the chief executive officer now directly owns […]
February 29, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CFO Jeffrey Thomas Elliott sold 2,710 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $154,171.90. Following the transaction, the chief financial officer now owns 8,054 shares of the […]
February 29, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 1,880 shares of Exact Sciences stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $106,953.20. Following the completion of the transaction, the executive vice president now directly owns 73,732 […]
February 29, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 1,021 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $59.72, for a total value of $60,974.12. Following the transaction, the executive vice president now owns 71,658 shares of the company’s stock, […]
February 29, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) insider Jacob A. Orville sold 1,879 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $106,896.31. Following the sale, the insider now owns 11,754 shares of the company’s stock, […]
February 28, 2024
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]